Evidence map›Paper›PMID 22248351›Full record

ArticleMolecular cytogenetics2012

Spectral Karyotyping for identification of constitutional chromosomal abnormalities at a national reference laboratory.

Arturo Anguiano, Boris T Wang, Shirong R Wang, Fatih Z Boyar, Loretta W Mahon, Mohamed M El Naggar, Peter H Kohn, Mary H Haddadin, Vladimira Sulcova, Adam H Sbeiti and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular cytogenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Bioinformatics tools allow targeted selection of chromosome enumeration probes and aneuploidy detection.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Arturo Anguiano *Quest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Boris T Wang *Quest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Shirong R WangQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Fatih Z BoyarQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Loretta W MahonQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Mohamed M El NaggarQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Peter H KohnQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Mary H HaddadinQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Vladimira SulcovaQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Adam H SbeitiQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Mervat S AyadQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Beverly J WhiteQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Charles M StromQuest Diagnostics Nichols Institute, San Juan Capistrano, CA 92690, USA.
Quest Diagnostics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spectral karyotyping is a diagnostic tool that allows visualization of chromosomes in different colors using the FISH technology and a spectral imaging system. To assess the value of spectral karyotyping analysis for identifying constitutional supernumerary marker chromosomes or derivative chromosomes at a national reference laboratory, we reviewed the results of 179 consecutive clinical samples (31 prenatal and 148 postnatal) submitted for spectral karyotyping. Over 90% of the cases were requested to identify either small supernumerary marker chromosomes (sSMCs) or chromosomal exchange material detected by G-banded chromosome analysis. We also reviewed clinical indications of those cases with marker chromosomes in which chromosomal origin was identified by spectral karyotyping. Our results showed that spectral karyotyping identified the chromosomal origin of marker chromosomes or the source of derivative chromosomal material in 158 (88%) of the 179 clinical cases; the identification rate was slightly higher for postnatal (89%) compared to prenatal (84%) cases. Cases in which the origin could not be identified had either a small marker chromosome present at a very low level of mosaicism (< 10%), or contained very little euchromatic material. Supplemental FISH analysis confirmed the spectral karyotyping results in all 158 cases. Clinical indications for prenatal cases were mainly for marker identification after amniocentesis. For postnatal cases, the primary indications were developmental delay and multiple congenital anomalies (MCA). The most frequently encountered markers were of chromosome 15 origin for satellited chromosomes, and chromosomes 2 and 16 for non-satellited chromosomes. We were able to obtain pertinent clinical information for 47% (41/88) of cases with an identified abnormal chromosome. We conclude that spectral karyotyping is sufficiently reliable for use and provides a valuable diagnostic tool for establishing the origin of supernumerary marker chromosomes or derivative chromosomal material that cannot be identified with standard cytogenetic techniques.

Identifiers

PMID22248351
PMCPMC3298509
OpenAlexW2097430926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.